Sweden

• NCT02426541

  Collaborator, Phase 4, Completed, 55 people, 27 Apr 2015

• Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study

  Employment, 1 Sept 2026

• Whole-body magnetic resonance imaging (MRI) or computed tomography (CT) screening for reducing morbidity and mortality from multiple diseases in asymptomatic adults

  Patents or royalties, 25 Aug 2026

• Comorbidity-adjusted life expectancy using comprehensive summary measures of medical history: nationwide, population-based study in Sweden

  Employment, 20 Aug 2026

• Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers

  Employment, 12 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov